Antidiabetic activity of Nigella sativa seed extract in cultured pancreatic β-cells, skeletal muscle cells, and adipocytes

Pharmaceutical Biology

Volumn 46, Issue 1-2, 2008, Pages 96-104

  Benhaddou Andaloussi, Ali ^a,b,c   Martineau, Louis C ^a,b,c   Spoor, Danielle ^a,b,c   Vuong, Tri ^a,b,c   Leduc, Charles ^a,b   Joly, Erik ^c,d   Burt, Andrew ^e   Meddah, Bouchra ^a,b,f   Settaf, Abdellatif ^f   Arnason, John T ^e   Prentki, Marc ^c,d   Haddad, Pierre S ^a,b,c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c Montreal Diabetes Research Center   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f MOHAMMED V UNIVERSITY   (Morocco)

Author keywords

Glucose uptake; Insulin secretion; Natural health products; Traditional medicine; Type 2 diabetes mellitus

Indexed keywords

INSULIN; NIGELLA SATIVA EXTRACT; ROSIGLITAZONE;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; INSULIN RELEASE; INSULIN SENSITIVITY; MUSCLE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PLANT SEED; RAT; SKELETAL MUSCLE;

NIGELLA SATIVA;

EID: 38849108660     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200701734810     Document Type: Article

References (43)

1. Alarcon-Aguilara FJ, Roman-Ramos R, Perez-Gutierrez S, Aguilar-Contreras A, Contreras-Webe CC, Flores-Saenza JL (1998): Study of the anti-hyperglycemic effect of plants used as antidiabetics. J Ethnopharmacol 61: 101-110.
2. Al-Awadi FM, Fatania H, Shamate U (1991): The effect of a plant mixture extract on liver gluconeogenesis in streptozotocin induced diabetic rats. Diab Res 18: 163-168.
3. Al-Awadi FM, Gumaa KA (1987): Studies on the activity of individual plants of an antidiabetic plant mixture. Acta Diabetol Lat 24: 37-41.
4. Al-Awadi FM, Khattar MA, Gumaa KA (1985): On the mechanism of the hypoglycaemic effect of a plant extract. Diabetologia 28: 432-434.
5. Al-Hader A, Aqel M, Hasan Z (1993): Hypoglycemic effects of the volatile oil of Nigella sativa seeds. Int J Pharmacog 31: 96-100.
6. Bailey CJ (2000): Metformin: A useful adjunct to insulin therapy? Diabet Med 17: 83-84.
7. Bell, GI, Burant CF, Takeda J, Gould GW (1993): Structure and function of ammalian facilitative sugar transporters. J Biol Chem 268: 19161-19164.
8. Bellakhdar, J, Claisse R, Fleurentin J, Younos C (1991): Repertory of standard herbal drugs in the Moroccan pharmacopoea. J Ethnopharmacol 35: 123-143.
9. Bianchi C, Penno G, Romero F, Del-Prato S, Miccoli, R (2007): Treating the metabolic syndrome. Expert Rev Cardiovasc Ther 5: 491-506.
10. Boutayeb A, Twisell EH, Achouayb K, Chetouani A (2004): A mathematical model or the burden of diabetes and its complications. BioMedical Engineering Online 3: 20-28.
11. Broca C, Breil V, Cruciani-Guglielmacci C, Mantechetti M, Rouault C, Derouet M, Riskalla S, Pau B, Petit P, Ribes G, Ktorza A, Gross R, Reach G, Taouis M (2004): Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat. Am J Physiol Endocrinol Metab 287: 463-471.
12. Chang L, Chiang SH, Saltiel AR (2004): Insulin signaling and the regulation of glucose transport. Mol Med 10: 65-71.
13. Cohen A, Horton ES (2007): Progress in the treatment of type 2 diabetes: New pharmacologic approaches to improve glycemic control. Curr Med Res Opin 23: 905-917.
14. Efrat S, Fusco-DeMane D, Lemberg H, al Emran O, Wang X (1995): Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc Natl Acad Sci USA, 92: 3576-3580.
15. El-Dakhakhny M, Mady N, Lembert N, Ammon HPT (2002): The hypoglycaemic effect of Nigella sativa oil is mediated by extrapancreatic actions. Planta Med 68: 465-466.
16. Fararh KM, Atoji Y, Shimizu Y, Shiina T, Nikami H, Takewaki T (2004): Mechanisms of the hypoglycaemic and immunopotentiating effects of Nigella sativa L. oil in streptozotocin-induced diabetic hamsters. Res Vet Sci 77: 123-129.
17. Fararh KM, Atoji Y, Shimizu Y, Takewaki T (2002): Insulinotropic properties of Nigella sativa oil in streptozotocin plus nicotinamide diabetic hamster. Res Vet Sci 73: 279-282. cardiovascular disease. Med Sci (Paris), 22; pp. 381-388.
18. Fleischer N, Chen C, Surana M, Leiser M, Rossetti L, Pralong W, Efrat S (1998): Functional analysis of a conditionally transformed pancreatic beta-cell line. Diabetes 47: 1419-1425.
19. Haddad PS, Dèpôt M, Settaf A, Cherrah Y (2001): Use of antidiabetic plants in Morocco and Quebec. Diabetes Care 24: 608-609.
20. Haddad PS, Martineau LC, Lyoussi B, Le PM (2006): Antibiabetic plants of North Africa and the Middle East. In: Traditional Medicines for Modern Times: Antibiabetic Plants (A. Soumyanath, ed.). Boca Raton, FL, CRC Press 12: 221-241.
21. He A, Liu X, Liu L, Chang Y, Fang F (2007): How many signals impinge on GLUT4 activation by insulin? Cell Signal 19: 1-7.
22. Henquin JC (2000): Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49: 1751-1760.
23. Hohmeier HE, Thigpen A, Tran VV, Davis R, Newgard CB (1998): Stable expression of manganese superoxide dismutase (Mn-SOD) in insulinoma cells prevents IL-1β- induced cytotoxicity and reduces nitric oxide production. J Clin Invest 101: 1811-1820.
24. Kanter M, Meral I, Yener Z, Ozbek H, Demir H (2003): Partial regeneration/proliferation of the β-cells in the Islets of Langerhans by Nigella sativa L. in streptozotocin-induced diabetic rats. Tohuku J Exp Med 201: 213-219.
25. Klip A, Marette A (1992): Acute and chronic signals controlling glucose transport in skeletal muscle. J Cell Biochem 48: 51-60.
26. Knaack D, Fiore DM, Surana M, Leiser M, Laurance M, Fusco-DeMane D, Hegre OD, Fleischer N, Efrat S (1994): Clonal insulinoma cell line that stably maintains correct glucose responsiveness. Diabetes 43: 1413-1407.
27. Konrad D, Rudich A, Bilani PJ, Patel N, Richardson C, Witters LA, Klip A (2005): Troglitazone causes acute mitochondrial membrane depolarisation and an AMPK-mediated increase in glucose phosphorylation in muscle cells. Diabetologia 48: 954-966.
28. Labhal A, Settaf A, Bennani-Kabchi N, Cherrah Y, Slaoui A, Hassar M (1997): Actions anti-obésité, hypocholestérolémiante et hypotriglycéridémiante de Nigella sativa chez le Psammomys obesus. Caducée 27: 26-28.
29. Labhal A, Settaf A, Zalagh F, Cherrah Y, Hassar M, Slaoui A (1999): Propriétés anti-diabétiques des graines de Nigella sativa chez le mérione shawi obése et diabétique. Espérance Méd 47: 72-74.
30. Lazar MA (2005): PPAR gamma, 10 years later. Biochimie 87: 9-13.
31. Le PM, Benhaddou-Andaloussi A, Elimadi A, Settaf A, Cherrah Y, Haddad PS (2004): The petroleum ether extract of Nigella sativa exerts lipid-lowering and insulin-sensitizing actions in the rat. J Ethnopharmacol 94: 251-259.
32. MacDonald PE, Ha XF, Wang GJ, Smukler SR, Sun AM, Gaisano HY, Salapatek AM, Backx PH, Wheeler MB (2001): Members of the Kv1 and Kv2 voltage-dependent K(+) channel families regulate insulin secretion. Mol Endocrinol 15: 1423-1435.
33. Marles RJ, Farnsworth NR (1995): Antidiabetic plants and their active constituents. Phytomedicine 2: 137-189.
34. Martineau LC, Couture A, Spoor DC, Benhaddou-Andaloussi A, Harris C, Meddah B, Leduc C, Burt A. Vuong T, Le MP, Prentki M, Bennett SA, Arnason JT, Haddad PS (2005): Anti-diabetic properties of the Canadian lowbush blueberry Vaccinium angustifolium Ait. Phytomedicine 13: 612-623.
35. Meece J (2007): Pancreatic islet dysfunction in type 2 diabetes: A rational target for incretin-based therapies. Curr Med Res Opin 23: 933-944.
36. Meral I, Yener Z, Kahraman T, Mert T (2001): Effect of Nigella sativa on glucose concentration, lipid peroxidation, antioxidant defence system and liver damage in experimentally-induced diabetic rabbits. J Vet Med A Physiol Pathol Clin Med 48: 593-599.
37. Rchid H, Chevassus H, Nmila R, Guiral C, Petit P, Chokairi M, Sauvaire Y (2004): Nigella sativa seed extracts enhance glucose-induced insulin release from rat-isolated Langerhans islets. Clin Pharmacol Fundam 18: 525-529.
38. Spoor DC, Martineau LC, Leduc C, Benhaddou-Andaloussi A, Meddah B, Harris C, Burt A, Fraser MH, Coonishish J, Joly E, Cuerrier A, Bennett SA, Johns T, Prentki M, Arnason JT, Haddad PS (2006): Selected plant species from the Cree pharmacopoeia of northern Quebec possess anti-diabetic potential. Can J Physiol Pharmacol 84: 847-858.
39. Vats V, Grover JK, Rathi SS (2002): Evaluation of antihyperglycemic and hypoglycaemic effect of Trigonella foenum-graecum Linn, Ocimum sanctum Linn and Pterocarpus marsupium Linn in normal and alloxanized diabetic rats. J Ethnopharmacol 79: 95-100.
40. Winder WW (2000): AMP-activated protein kinase: Possible target for treatment of type 2 diabetes. Diabetes Technol Ther 2: 441-448.
41. Yamaguchi S, Katahira H, Ozawa S, Nakamichi Y, Tanaka T, Shimoyama T, Takahashi K, Yoshimoto K, Imaizumi MO, Nagamatsu S, Ishida H (2005): Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 289: E643-649.
42. Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS (2003): Systematic reviewof herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 26: 1277-1294.
43. Ziyyat A, Legssyer A, Mekhfi H, Dassouli A, Serhrouchni M, Benjelloun W (1997): Phytotherapy of hypertension and diabetes in oriental Morocco. J Ethnopharmacol 58: 45-55.